The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1142
October 28, 2002
View Complete Issue         Table of Contents 2019 
Acetaminophen Safety
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Acetaminophen Safety
October 28, 2002 (Issue: 1142)
An FDA panel has recommended that stronger warnings about hepatotoxicity be added to the labeling for acetaminophen (www.fda.gov, search "acetaminophen hepatotoxicity").
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Acetaminophen Safety
Article code: 1142a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.